Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1997 5
1998 4
1999 1
2000 5
2001 4
2003 1
2004 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

22 results
Results by year
Filters applied: . Clear all
Page 1
Cost-effectiveness of HIV postexposure prophylaxis following sexual or injection drug exposure in 96 metropolitan areas in the United States.
Pinkerton SD, Martin JN, Roland ME, Katz MH, Coates TJ, Kahn JO. Pinkerton SD, et al. AIDS. 2004 Oct 21;18(15):2065-73. doi: 10.1097/00002030-200410210-00011. AIDS. 2004. PMID: 15577628
Efficacy and cost-effectiveness of the first generation of HIV prevention interventions for people with severe and persistent mental illness.
Johnson-Masotti AP, Weinhardt LS, Pinkerton SD, Otto-Salaj LL. Johnson-Masotti AP, et al. J Ment Health Policy Econ. 2003 Mar;6(1):23-35. J Ment Health Policy Econ. 2003. PMID: 14578545 Review.
Sexually transmitted diseases and the increased risk for HIV transmission: implications for cost-effectiveness analyses of sexually transmitted disease prevention interventions.
Chesson HW, Pinkerton SD. Chesson HW, et al. J Acquir Immune Defic Syndr. 2000 May 1;24(1):48-56. doi: 10.1097/00126334-200005010-00009. J Acquir Immune Defic Syndr. 2000. PMID: 10877495
When is an HIV infection prevented and when is it merely delayed?
Pinkerton SD, Chesson HW, Holtgrave DR, Kassler W, Layde PM. Pinkerton SD, et al. Eval Rev. 2000 Jun;24(3):251-71. doi: 10.1177/0193841X0002400301. Eval Rev. 2000. PMID: 10947517 Review.
A relative risk-based, disease-specific definition of sexual abstinence failure rates.
Pinkerton SD. Pinkerton SD. Health Educ Behav. 2001 Feb;28(1):10-20. doi: 10.1177/109019810102800102. Health Educ Behav. 2001. PMID: 11213138
Secondary HIV transmission rates in a mixed-gender sample.
Pinkerton SD, Abramson PR, Kalichman SC, Catz SL, Johnson-Masotti AP. Pinkerton SD, et al. Int J STD AIDS. 2000 Jan;11(1):38-44. doi: 10.1258/0956462001914887. Int J STD AIDS. 2000. PMID: 10667899
Updates of cost of illness and quality of life estimates for use in economic evaluations of HIV prevention programs.
Holtgrave DR, Pinkerton SD. Holtgrave DR, et al. J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Sep 1;16(1):54-62. doi: 10.1097/00042560-199709010-00009. J Acquir Immune Defic Syndr Hum Retrovirol. 1997. PMID: 9377126
How HIV treatment advances affect the cost-effectiveness of prevention.
Pinkerton SD, Holtgrave DR. Pinkerton SD, et al. Med Decis Making. 2000 Jan-Mar;20(1):89-94. doi: 10.1177/0272989X0002000111. Med Decis Making. 2000. PMID: 10638541
Using cost-effectiveness league tables to compare interventions to prevent sexual transmission of HIV.
Pinkerton SD, Johnson-Masotti AP, Holtgrave DR, Farnham PG. Pinkerton SD, et al. AIDS. 2001 May 4;15(7):917-28. doi: 10.1097/00002030-200105040-00012. AIDS. 2001. PMID: 11399964
Cost-effectiveness of a community-level HIV risk reduction intervention.
Pinkerton SD, Holtgrave DR, DiFranceisco WJ, Stevenson LY, Kelly JA. Pinkerton SD, et al. Am J Public Health. 1998 Aug;88(8):1239-42. doi: 10.2105/ajph.88.8.1239. Am J Public Health. 1998. PMID: 9702159 Free PMC article.
22 results
Jump to page
Feedback